BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Juneja P, Tripathi DM, Kaur S. Revisiting the gut-liver axis: gut lymphatic system in liver cirrhosis and portal hypertension. Am J Physiol Gastrointest Liver Physiol 2022;322:G473-9. [PMID: 35195034 DOI: 10.1152/ajpgi.00271.2021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Tilg H, Adolph TE, Trauner M. Gut-liver axis: Pathophysiological concepts and clinical implications. Cell Metab 2022;34:1700-18. [PMID: 36208625 DOI: 10.1016/j.cmet.2022.09.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Yan M, Hu D, Wu Z, Lai J, Zhang L, Zhang H, Li S, Bai L. Survival Fate of Hepatic Stem/Progenitor and Immune Cells in a Liver Fibrosis/Cirrhosis Animal Model and Clinical Implications. Animal Models and Experimental Research in Medicine [Working Title] 2022. [DOI: 10.5772/intechopen.106220] [Reference Citation Analysis]
3 Iwasa M, Eguchi A, Tamai Y, Shigefuku R, Nakagawa R, Hasegawa H, Kondo J, Morikawa M, Miyoshi E, Nakagawa H. Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease. Front Med 2022;9. [DOI: 10.3389/fmed.2022.982128] [Reference Citation Analysis]
4 Liu J, Yu C. Lymphangiogenesis and Lymphatic Barrier Dysfunction in Renal Fibrosis. IJMS 2022;23:6970. [DOI: 10.3390/ijms23136970] [Reference Citation Analysis]